Major AI Health Breakthroughs Will Land in 1 to 3 Years | Ben Liu artwork

Major AI Health Breakthroughs Will Land in 1 to 3 Years | Ben Liu

MTS

October 29, 2026

Formation Bio co-founder and CEO Benjamin Liu breaks down the company's new $600M fund to license stalled drug candidates and run them through clinical trials with AI.

0:00

Benjamin Liu

There's a lot of things over the next few quarters that we're really excited to announce, and they fit some of the themes that we discussed that help you maybe walk, live longer and healthier. And we've made a lot of really kind of progress on those kinds of programs. So stay tuned, and we're excited to share more when we can. But I think over the next one, two, three years, there's gonna be a lot of excited things.

And ideally, what gets us up in the morning the most is developing drugs or diseases where there aren't any treatments.

0:32

Sophia

Everyone, welcome back to MTS. We are joined today by Benjamin Liu. He is the co-founder and CEO of Formation Bio. And earlier today, they just announced their 600 million dollar fund to buy and license stalled drugs and push them through clinical trials faster with AI. So Ben, welcome to MTS.

0:51

Benjamin Liu

Thanks so much for having me.

0:52

Sophia

Thank you for joining. I know you were on MTS earlier talking all about Formation Bio's large thesis, and now you guys have this big announcement going on. If you had to summarize your big thesis, your big worldview, how would you share that?

1:06

Benjamin Liu

Yeah, related to the fact that it's becoming increasingly clear that drug discovery is getting so much more efficient. And there's this kind of fundamental impendence mismatch in our industry where drug discovery is getting more and more kind of abundant with all the developments in AI. You saw what Anthropix is doing, they're doing incredible work. But all the biotech platform companies, AI discovery companies means that there's been a doubling of number of discovered drug candidates in the past 10 years, even before AI.

But the number of approved drugs in those same past 10 years has been kind of constant at 50 a year. And so what we kind of see is this kind of deluge of an acceleration of drug discovery abundance and some new candidates, but the fundamental bottleneck is drug development and clinical trials. And so as a company, we actually don't do discovery. We look to license drugs that are discovered, pair them with the best human drug pickers. AI systems allow us to understand what diseases to match them to. And we built the ability to run drug development end to end a lot more efficiently. And so we think that in a world where drug discovery is increasingly more efficient, that the biggest bottleneck to solve is drug development. And so with this fund, what we're able to do is to specifically finance what we believe will be an increasingly important asset class, which is all these discovered drugs that are two to four years away from clinical value inflection. And when a single clinical trial can cost 50 million or even 100 million in various cases, that's going to be the bottleneck for a pretty long time.

2:36

Sophia

Yeah. Benjamin, I'm so glad that you guys are doing this. It's been crazy being on MTS, actually talking to people and understanding how AI is really increasing the discovery process. And the fact that we might have discoveries for cancer, for Alzheimer's, and all of these incredible drugs, but they never get developed. They never actually get diffused into society. We don't get to have that impact into our everyday lives. It's crazy. It's like we have the solution. Yeah. But we don't actually get to feel it. So how does this actually happen? How do we actually get it diffused? How does it enter society?

3:06

Benjamin Liu

Yeah. A big bottleneck is the capital and capabilities to run phase one testing, phase two testing, phase three testing. So as you alluded to, it's been a doubling number of discovered drugs the past 10 years now with AI, but also just biotech productivity. There's like 2.5x drugs per target. That's going to grow to 5, 10, if not 100x over time.

We won't fundamentally deliver new medicines to patients if we aren't able to address what currently is inhibiting these drugs from diffusing, as you put it, which is running the trials faster and more efficiently. That's not just the capital needed, but also expertise capabilities, manufacturing, the drug development process.

When you have a bunch of discovered drug, I think the value shifts towards, can you match the right drug to the right disease? Can you design the right studies? Can you have a lot of great human taste in understanding how best to position the drugs to ultimately serve white space or unmet need? What we built as a company is a lot of the AI systems allow us to look at every single drug in the world, match the right drug to the right disease, design the studies more efficiently, but also build what we call attacker AI enabled, clinical trial engines in the industry called a CRO. That allows us to ultimately bring new medicines to patients. I think what's maybe underappreciated is like discovered drug candidates by themselves won't result in new medicines if they're not developed through the drug development process more efficiently.

Read the other 24 minutes of this episode here.

$15 gets you this episode and 99 more. Credits never expire. After checkout, one link brings you back here to read it.

Not what you expected? Full refund within 14 days.

Thousands of transcripts fetched by people building searchable podcast archives

Fetch transcripts with code

The same credits work from a script or an AI agent. The demo key returns a sample episode in full, no card needed:

request
curl -H "x-api-key: pt_demo" \
  https://spoken.md/transcripts/1000651996090

Markdown with the speakers named, for your notes, your knowledge base, or anything that makes HTTP calls.

From $0.10 per transcript. No subscription. Credits never expire. Prices exclude VAT, added at checkout for EU customers. Not what you expected? Email us within 14 days with 20 or fewer credits used and we refund the pack in full.

Using your own key:

request
curl -H "x-api-key: YOUR_KEY" \
  https://spoken.md/transcripts/1000798684956